Articles On Avita Medical (ASX:AVH)

Title Source Codes Date
Top 10 at 10: These ASX lithium and gold stocks are making hay on Monday

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead AVH 1 year ago
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal

ASX health stocks rise in the past five days outperforming broader markets Avita Medical product sales up 40% on pcp to US$10.5 million in Q1 FY23 Proteomics International Laboratories inks a deal with Sonic Healthcare USA Healthcare and...

Stockhead AVH 1 year ago
Market Highlights: Fresh US banking crisis, UK rate at 15-year high, and 5 ASX small caps to watch today

The ASX is set to fall today on renewed US banking crisis The BoE raised its rates to highest in 15 years Gold was down despite Wall Street selloff   The ASX is poised to open lower on Friday as the US banking crisis reared its ugly head...

Stockhead AVH 1 year ago
Dr Boreham’s Crucible: Impedimed

Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life. By Tim Boreham ASX code: ((IPD)) Share price: 18.5 cents Shares on issue: 1,787,664,914 Market cap: $330.7 million Chief executive office...

FNArena AVH 1 year ago
5 top ASX shares that would have more than doubled your money in 2023

Investing in ASX shares has been a profitable venture for most investors in 2023. Since the opening bell on 3 January, the All Ordinaries Index (ASX: XAO) has gained 5%. And that figure doesn’t include any dividend payouts made by many o...

Motley Fool AVH 1 year ago
The Overnight Report: Here We Go Again?

World Overnight SPI Overnight 7316.00 – 38.00 – 0.52% S&P ASX 200 7322.00 – 8.40 – 0.11% S&P500 4071.63 – 65.41 – 1.58% Nasdaq Comp 11799.16 – 238.05 – 1.98% DJIA 33530.83 – 344.57 – 1.02% S&P500 VIX 18.76 + 1.87 1...

FNArena AVH 1 year ago
Weekly Ratings, Targets, Forecast Changes – 21-04-23

By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro...

FNArena AVH 1 year ago
The Overnight Report: Bring It On

World Overnight SPI Overnight 7376.00 – 17.00 – 0.23% S&P ASX 200 7381.50 + 19.90 0.27% S&P500 4151.32 + 13.68 0.33% Nasdaq Comp 12157.72 + 34.26 0.28% DJIA 33987.18 + 100.71 0.30% S&P500 VIX 16.95 – 0.12 – 0.70%...

FNArena AVH 1 year ago
Weekly Ratings, Targets, Forecast Changes – 14-04-23

By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro...

FNArena AVH 1 year ago
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update

ASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% after BIS tech named in latest US NCCN guidelines for lymphoedema  EBR Systems to release top line results at cardiac conference Heart Rhythm...

Stockhead AVH 1 year ago
Dr Boreham’s Crucible: Avita Medical

Tim Boreham highlights the global addressable market opportunity for Avita Medical's skin graft technology, made famous by the Bali bombings. By Tim Boreham ASX code: AVH (Chess depositary instruments); Nasdaq code: RCEL (US shares) Shares...

FNArena AVH 1 year ago
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?

Several ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix Pharmaceuticals is chasing renal cancer imaging approval for TLX-250 CDx Aroa is awaiting an FDA decision on the required regulatory pathway...

Stockhead AVH 1 year ago
7 ASX All Ordinaries shares smashing new 52-week highs today

It’s been a pretty positive day for ASX shares and the All Ordinaries Index (ASX: XAO) so far this Thursday. After a rocky start, the All Ords is tentatively in the green at the time of writing, having put on 0.12%, which lifts the Index t...

Motley Fool AVH 1 year ago
The Overnight Report: The Need For Speed

World Overnight SPI Overnight 7272.00 – 60.00 – 0.82% S&P ASX 200 7364.70 + 36.10 0.49% S&P500 3986.37 – 62.05 – 1.53% Nasdaq Comp 11530.33 – 145.41 – 1.25% DJIA 32856.46 – 574.98 – 1.72% S&P500 VIX 19.59 + 0.98 5....

FNArena AVH 1 year ago
The Overnight Report: All Quiet

World Overnight SPI Overnight 7279.00 – 12.00 – 0.16% S&P ASX 200 7328.60 + 45.00 0.62% S&P500 4048.42 + 2.78 0.07% Nasdaq Comp 11675.74 – 13.27 – 0.11% DJIA 33431.44 + 40.47 0.12% S&P500 VIX 18.61 + 0.12 0.65% U...

FNArena AVH 1 year ago
Weekly Ratings, Targets, Forecast Changes – 03-03-23

By Mark Woodruff Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the purpose of broker rating corre...

FNArena AVH 1 year ago
The Overnight Report: Not With A Bang

World Overnight SPI Overnight 7177.00 – 21.00 – 0.29% S&P ASX 200 7258.40 + 33.60 0.47% S&P500 3970.15 – 12.09 – 0.30% Nasdaq Comp 11455.54 – 11.44 – 0.10% DJIA 32656.70 – 232.39 – 0.71% S&P500 VIX 20.70 – 0.25 – 1...

FNArena AVH 1 year ago
Guess which ASX All Ordinaries stock has soared 50% in 3 days after reporting

The ASX All Ordinaries Index (ASX: XAO) has had a bumpy few days of trading recently. Last Friday, the All Ords rose by a decent 0.3%, only to tank by a nasty 1.2% yesterday. Today so far, the Index has bounced back up by 0.48%. But let’s...

Motley Fool AVH 1 year ago
The Overnight Report: Range-Bound?

World Overnight SPI Overnight 7201.00 + 34.00 0.47% S&P ASX 200 7224.80 – 82.20 – 1.12% S&P500 3982.24 + 12.20 0.31% Nasdaq Comp 11466.98 + 72.04 0.63% DJIA 32889.09 + 72.17 0.22% S&P500 VIX 20.95 – 0.72 – 3.32%...

FNArena AVH 1 year ago
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Stockhead AVH 1 year ago
FNArena Corporate Results Monitor – 27-02-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ASB)) - Austal ((AFG)) - Australian Finance Group ((AVH)) - Avita Medical ((BRI)) - Big River Industries ((SQ2)) - Block ((BXB)) - Brambles ((CB...

FNArena AVH 1 year ago
Four sectors trading at least 1% higher; ASX up 0.35% at noon

ShareCafeFour sectors trading at least 1% higher; ASX up 0.35% at noon by Peter Milios   Industrials, Information Technology, Utilities and Real Estate are trading at least 1 per cent higher, responding to strong figures from the US markets...

ShareCafe AVH 1 year ago
Stocks of the Hour: Resource Base, AVITA Medical, Selfwealth

24 Feb 2023 - A snapshot of the stocks on the move featuring Resource Base (ASX:RBX), AVITA Medical (ASX:AVH) and Selfwealth (ASX:SWF).

FNN AVH 1 year ago
Stocks of the Hour: RBX, AVH, SWF

ShareCafeStocks of the Hour: RBX, AVH, SWF                    Resource Base (ASX:RBX) has secured an option to acquire two highly prospective lithium projects in Québec. Resource Base Non-Executive Chairman, Maurice Feilich, commented...

ShareCafe AVH 1 year ago
3 ASX shares I dream of owning at the right price

There are many ASX shares vying for a position in my portfolio at any single point in time. Companies that exhibit impressive revenue growth, sell incredibly valuable products/services, and are leaders in their fields. However, as amazing...

Motley Fool AVH 1 year ago
Here’s why Morningstar reckons the ASX healthcare sector is on road to recovery

Morningstar sees ASX healthcare sector as fair value with some buying opportunities Healthcare stocks viewed as defensive and insulated from rising inflation Morningstar has several healthcare picks for 2023 with last year’s headwinds like...

Stockhead AVH 1 year ago
“Your Stock Request” – 22 December 2022

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fairmont Equities AVH 1 year ago
AVITA Medical submits FDA PMA application to expand indication

Regenerative medicine company AVITA Medical (ASX:AVH) has announced the submission of a Premarket Approval application to the US FDA for its RECELL System.

BiotechDispatch AVH 1 year ago
Investing in ASX biotech ft. Dr Megan Baldwin & Jeremy Curnock Cook

Jeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management business specialising in biotechnology investments in Australia and globally. He is also a director of Avita Medical Inc (ASX: AVH). Jeremy...

Rask Media AVH 1 year ago
3 ASX All Ordinaries shares that defied today’s sell-off to leap higher

The All Ordinaries Index (ASX: XAO) fell 0.65% today, but three ASX shares charged higher. The Magnis Energy Technologies Ltd (ASX: MNS), Cettire Ltd (ASX: CTT) and Avita Medical Inc (ASX: AVH) share prices all outperformed the index tod...

Motley Fool AVH 1 year ago
AVITA Medical submits to US FDA with the goal of expanding indication for RECELL

Regenerative medicine company AVITA Medical (ASX:AVH) has submitted to the US FDA for premarket approval supplement application for its RECELL System.

BiotechDispatch AVH 1 year ago
Purpose-driven startups win big at Pause Awards

Purpose focused startups such as Great Wrap, Bare Cremation, and Separation Guide, are among the major winners of the annual Pause Awards. Held in Melbourne and backed by VicGov, the 5th annual Pause Awards recognise innovation and people b...

Startup Daily AVH 1 year ago
Is there an $8 billion ‘pot of gold at the end of the rainbow’ for investors in this ASX healthcare share?

Shares in the spray-on skin company Avita Medical Inc (ASX: AVH) closed 2.6% higher on Friday at $1.96. The ASX healthcare share may be down 42% over the year to date, but it appears to be making a comeback. The Avita share price is up a...

Motley Fool AVH 1 year ago
2 absolute bargain ASX shares to buy right now: analyst

Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Bell Direct market analyst Grady Wulff names two cheap ASX shares to buy and one to ho...

Motley Fool AVH 1 year ago
Australian Broker Call *Extra* Edition – Nov 21, 2022

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

FNArena AVH 2 years ago
ASX Close: US inflation surprise lifts stocks to five-month high

A global relief rally catapulted the ASX 200 to a five-month high after Wall Street celebrated a slowdown in inflation with its biggest advance since 2020. The S&P/ASX 200 wrapped up a strong week with a rise of 194 points or 2.79 pe...

themarketherald.com.au AVH 2 years ago
ScoPo’s Powerplays: Stress eases as ASX health stocks enjoy much needed rally

ASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation figures Wound care company Avita rises 24% and biotech Antisense is up 18% for past five days Fertility company Monash IVF provides solid H1...

Stockhead AVH 2 years ago
Avita Medical (ASX:AVH) bolsters revenue guidance, reduces quarterly net loss

Avita Medical (AVH) reports a 30-per-cent bump to year-on-year revenue over the September quarter of this yearOver the three-month period, the company posted $9 million in quarterly commercial revenue compared to just under $7 million over...

themarketherald.com.au AVH 2 years ago
ASX Update: Five-month high as inflation fears abate

Wall Street’s best night since 2020 fuelled strong gains on the ASX, powering the benchmark to its highest level since June. The S&P/ASX 200 rallied 163 points or 2.33 per cent by mid-session. The rally followed huge gains in the US...

themarketherald.com.au AVH 2 years ago
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead

Cynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay Healthcare and Avita gave solid quarterly updates Cynata and Proteomics’ patents update Cynata Therapeutics (ASX:CYP) rose 8pc this mornin...

Stockhead AVH 2 years ago
ASX 200 rises at open; Pinnacle up over 14%

Highlights Australian shares opened higher on Friday. The ASX 200 gained in the opening trade, rising 36.10 points, or 0.52%, to 7,000.10. On Thursday, the benchmark index ended 0.5% higher at 6,964 points. Australian...

Kalkine Media AVH 2 years ago
ASX Health Stocks: Avita makes crucial announcement on its pivotal RECELL trial, shares up 9pc

Avita Medical successfully achieved two co-primary endpoints Noxopharm received $5.011 million in R&D rebate Avita makes crucial progress in pivotal trial Avita Medical (ASX:AVH) announced that it has achieved the co-primary endpoints...

Stockhead AVH 2 years ago
“Your Stock Request” – 10 November 2022

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fairmont Equities AVH 2 years ago
The ASX All Ords share that’s a better, cheaper buy than Polynovo: Wilsons

Analysts at Wilsons have put the spotlight on one All Ordinaries Index (ASX: XAO) share it prefers over the Polynovo Ltd (ASX: PNV) share price. Polynovo shares fell 3.23% today to $1.98. For perspective, the All Ordinaries Index climbed...

Motley Fool AVH 2 years ago
Innovation never sleeps: Franklin Templeton says watch these 5 big tech shifts this quarter

Franklin Templeton says innovation accelerates despite recessions, pandemic, wars Expect advancements in sectors like gene therapy and augmented reality in healthcare New ways to grab our attention are reinventing the media industry Frank...

Stockhead AVH 2 years ago
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Stockhead AVH 2 years ago
AVITA Medical (ASX:AVH) appoints James Corbett as CEO

Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He...

themarketherald.com.au AVH 2 years ago
3 ASX All Ordinaries shares defying today’s rout to surge higher

The S&P/ASX All Ordinaries Index (ASX: XAO) is deep in the red today after a hot US inflation report sent Wall Street into a tailspin overnight. At the time of writing, the All Ords index has slipped 2.6% to 7,065 points. The S&P/A...

Motley Fool AVH 2 years ago
Market Highlights: US bans Nvidia chips in China; and 5 ASX small caps to watch on Friday

Local markets set to open higher, Friday Late rally sees the S&P 500 close ahead, first time in five days  US China trade war flares as chipmaker banned  Local shares are set to open higher on Friday. At 8am AEST, the ASX 200 Septembe...

Stockhead AVH 2 years ago
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

Stockhead AVH 2 years ago